Berentzen-Gruppe Aktiengesellschaft (FRA:BEZ)
Germany · Delayed Price · Currency is EUR 4.170
+0.150 (3.73%)
Last updated: Aug 1, 2025
Intra-Cellular Therapies Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| 181.94 | 185.65 | 174.22 | 146.11 | 154.59 | Upgrade | |
Revenue Growth (YoY) | -2.00% | 6.56% | 19.24% | -5.49% | -7.65% | Upgrade |
Cost of Revenue | 107.2 | 113.39 | 99.13 | 81.63 | 91.46 | Upgrade |
Gross Profit | 74.74 | 72.26 | 75.09 | 64.48 | 63.13 | Upgrade |
Selling, General & Admin | 34.82 | 33.49 | 32.32 | 30.34 | 28.39 | Upgrade |
Other Operating Expenses | 26.71 | 26.24 | 29.43 | 20.3 | 22.19 | Upgrade |
Operating Expenses | 70.29 | 68.03 | 70.06 | 59.29 | 59.5 | Upgrade |
Operating Income | 4.45 | 4.23 | 5.03 | 5.19 | 3.63 | Upgrade |
Interest Expense | -4.58 | -3.93 | -1.68 | -1.43 | -1.5 | Upgrade |
Interest & Investment Income | 0.17 | 0.13 | 0.06 | 0.06 | 0.1 | Upgrade |
Currency Exchange Gain (Loss) | - | - | 0.41 | 0.04 | - | Upgrade |
Other Non Operating Income (Expenses) | 0.02 | -0.07 | 0.1 | 0.64 | 0.52 | Upgrade |
EBT Excluding Unusual Items | 0.06 | 0.36 | 3.92 | 4.49 | 2.75 | Upgrade |
Gain (Loss) on Sale of Investments | - | - | -0.01 | - | - | Upgrade |
Gain (Loss) on Sale of Assets | - | - | - | - | 0.08 | Upgrade |
Asset Writedown | -2.78 | - | -1.3 | - | -1.38 | Upgrade |
Other Unusual Items | 2.18 | 1.74 | 1.56 | 0.81 | 0.81 | Upgrade |
Pretax Income | -0.54 | 2.1 | 4.17 | 5.3 | 2.26 | Upgrade |
Income Tax Expense | 0.71 | 1.24 | 2.07 | 1.64 | 1.02 | Upgrade |
Net Income | -1.25 | 0.87 | 2.1 | 3.66 | 1.23 | Upgrade |
Net Income to Common | -1.25 | 0.87 | 2.1 | 3.66 | 1.23 | Upgrade |
Net Income Growth | - | -58.83% | -42.63% | 197.00% | -74.96% | Upgrade |
Shares Outstanding (Basic) | 9 | 9 | 9 | 9 | 9 | Upgrade |
Shares Outstanding (Diluted) | 9 | 9 | 9 | 9 | 9 | Upgrade |
EPS (Basic) | -0.13 | 0.09 | 0.22 | 0.39 | 0.13 | Upgrade |
EPS (Diluted) | -0.13 | 0.09 | 0.22 | 0.39 | 0.13 | Upgrade |
EPS Growth | - | -58.83% | -42.63% | 197.00% | -74.97% | Upgrade |
Free Cash Flow | 1 | -12.13 | -3.78 | 3.62 | 8.97 | Upgrade |
Free Cash Flow Per Share | 0.11 | -1.29 | -0.40 | 0.39 | 0.95 | Upgrade |
Dividend Per Share | 0.110 | 0.090 | 0.220 | 0.220 | 0.130 | Upgrade |
Dividend Growth | 22.22% | -59.09% | - | 69.23% | -53.57% | Upgrade |
Gross Margin | 41.08% | 38.92% | 43.10% | 44.13% | 40.84% | Upgrade |
Operating Margin | 2.44% | 2.28% | 2.88% | 3.55% | 2.35% | Upgrade |
Profit Margin | -0.69% | 0.47% | 1.21% | 2.51% | 0.80% | Upgrade |
Free Cash Flow Margin | 0.55% | -6.53% | -2.17% | 2.47% | 5.80% | Upgrade |
EBITDA | 11.66 | 11.14 | 12.13 | 12.7 | 11.42 | Upgrade |
EBITDA Margin | 6.41% | 6.00% | 6.96% | 8.69% | 7.39% | Upgrade |
D&A For EBITDA | 7.21 | 6.91 | 7.1 | 7.51 | 7.79 | Upgrade |
EBIT | 4.45 | 4.23 | 5.03 | 5.19 | 3.63 | Upgrade |
EBIT Margin | 2.44% | 2.28% | 2.88% | 3.55% | 2.35% | Upgrade |
Effective Tax Rate | - | 58.85% | 49.63% | 30.92% | 45.35% | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.